GLP-1 drugs linked to lower fracture risk in adults with type 2 diabetes
New research by UCLA Health has found GLP-1 medications may reduce the risk of serious fractures for adults with type 2 diabetes.
9 hours ago
0
2
Pharmacologic Substance: Dipeptidyl-Peptidase IV Inhibitors
Medical news and research articles
Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest
Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related cancers, namely lung, breast, colorectal, and liver cancers. In addition, GLP-1 receptor (GLP-1R) expression ...
May 22, 2026
0
24
Could Ozempic help people whose cancer has spread to the brain?
Weight-loss injections that have become famous for helping people shed pounds may also help some patients with advanced cancer live longer when the disease has spread to the brain, according to a new study.
Mar 22, 2026
0
10
Patient data show diabetes medicine could save thousands more lives a year
Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new study led by researchers at the London School of Hygiene & Tropical Medicine (LSHTM) and UCL. Using ...
Feb 10, 2026
0
16
Findings suggest that certain medications for type 2 diabetes reduce risk of dementia
A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.
Jan 15, 2026
0
12
